Binding affinity of amyloid oligomers to cellular membranes is a generic indicator of cellular dysfunction in protein misfolding diseases

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Evangelisti, Elisa ^a   Cascella, Roberta ^a   Becatti, Matteo ^a   Marrazza, Giovanna ^a   Dobson, Christopher M ^b   Chiti, Fabrizio ^a   Stefani, Massimo ^a   Cecchi, Cristina ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; AMYLOID BETA PROTEIN; CALCIUM; CHOLESTEROL; ESCHERICHIA COLI PROTEIN; GANGLIOSIDE GM1; GLUTAMATE RECEPTOR; HYPF PROTEIN, E COLI; PROTEIN BINDING; TRANSFERASE;

BIOLOGICAL MODEL; CELL MEMBRANE; CYTOSOL; HUMAN; METABOLISM; PROTEIN MULTIMERIZATION; PROTEOSTASIS DEFICIENCY; SURFACE PLASMON RESONANCE; TUMOR CELL LINE;

AMYLOID; AMYLOID BETA-PEPTIDES; CALCIUM; CARBOXYL AND CARBAMOYL TRANSFERASES; CELL LINE, TUMOR; CELL MEMBRANE; CHOLESTEROL; CYTOSOL; ESCHERICHIA COLI PROTEINS; G(M1) GANGLIOSIDE; HUMANS; MODELS, BIOLOGICAL; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEOSTASIS DEFICIENCIES; RECEPTORS, GLUTAMATE; SURFACE PLASMON RESONANCE;

EID: 84987916580     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep32721     Document Type: Article

References (55)

1. Bemporad, F. & Chiti, F. Protein misfolded oligomers: experimental approaches, mechanism of formation, and structure-toxicity relationships. Chem. Biol. 19, 315-327 (2012).
2. Martins, I. C. et al. Lipids revert inert Abeta amyloid fibrils to neurotoxic protofibrils that affect learning in mice. EMBO J. 27, 224-233 (2008).
3. Cohen, S. I. et al. Proliferation of amyloid-β 42 aggregates occurs through a secondary nucleation mechanism. Proc. Natl. Acad. Sci. USA. 110, 9758-9763 (2013).
4. Kinnunen, P. J. K. Amyloid formation on lipid membrane surfaces. Open Biol. J. 2, 163-175 (2009).
5. Lukiw, W. J. Alzheimer's disease (AD) as a disorder of the plasma membrane. Front Physiol. 4, 24 (2013).
6. Cecchi, C. & Stefani, M. The amyloid-cell membrane system. The interplay between the biophysical features of oligomers/fibrils and cell membrane defines amyloid toxicity. Biophys. Chem. 182, 30-43 (2013).
7. Bucciantini, M. et al. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature 416, 507-511 (2002).
8. Glabe, C. G. & Kayed, R. Common structure and toxic function of amyloid oligomers implies a common mechanism of pathogenesis. Neurology 66, S74-S78 (2006).
9. Knowles, T. P., Vendruscolo, M. & Dobson, C. M. The amyloid state and its association with protein misfolding diseases. Nat. Rev. Mol. Cell. Biol. 15, 384-396 (2014).
10. Campioni, S. et al. A causative link between the structure of aberrant protein oligomers and their toxicity. Nat. Chem. Biol. 6, 140-147 (2010).
11. Cremades, N. et al. Direct observation of the interconversion of normal and toxic forms of a-synuclein. Cell 149, 1048-1059 (2012).
12. Ladiwala, A. R. et al. Conformational differences between two amyloid beta oligomers of similar size and dissimilar toxicity. J. Biol. Chem. 287, 24765-24773 (2012).
13. Krishnan, R. et al. Conserved features of intermediates in amyloid assembly determine their benign or toxic states. Proc. Natl. Acad. Sci. USA. 109, 11172-11177 (2012).
14. Liu, P. et al. Quaternary structure defines a large class of amyloid-β oligomers neutralized by sequestration. Cell Rep. 11, 1760-1771 (2015).
15. Zampagni, M. et al. A comparison of the biochemical modifications caused by toxic and non-toxic protein oligomers in cells. J. Cell. Mol. Med. 15, 2106-2116 (2011).
16. Tatini, F. et al. Amyloid-β oligomer synaptotoxicity is mimicked by oligomers of the model protein HypF-N. Neurobiol. Aging 34, 2100-2109 (2013).
17. Mannini, B. et al. Toxicity of protein oligomers is rationalized by a function combining size and surface hydrophobicity. ACS Chem. Biol. 9, 2309-2317 (2014).
18. Diaz, J. C., Simakova, O., Jacobson, K. A. Arispe & Pollard, H. B. N. Small molecule blockers of the Alzheimer Abeta calcium channel potently protect neurons from Abeta cytotoxicity. Proc. Natl. Acad. Sci. USA 106, 3348-3353 (2009).
19. Decker, H. et al. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-beta peptide oligomers. J. Neurochem. 115, 1520-1529 (2010).
20. Evangelisti, E. et al. Membrane lipid composition and its physicochemical properties define cell vulnerability to aberrant protein oligomers. J. Cell. Sci. 125, 2416-2427 (2012).
21. Malchiodi-Albedi, F. et al. Lipid raft disruption protects mature neurons against amyloid oligomer toxicity. Biochim. Biophys. Acta 1802, 406-415 (2010).
22. Schengrund, C. L. Lipid rafts: keys to neurodegeneration. Brain Res. Bull. 82, 7-17 (2010).
23. Pernber, Z., Blennow, K., Bogdanovic, N., Mansson, J. E. & Blomqvist, M. Altered distribution of the gangliosides GM1 and GM2 in Alzheimer's disease. Dement Geriatr. Cogn. Disord. 33, 174-188 (2012).
24. Yamamoto, N., Matsubara, T., Sato, T. & Yanagisawa, K. Age-dependent high-density clustering of GM1 ganglioside at presynaptic neuritic terminals promotes amyloid beta-protein fibrillogenesis. Biochim. Biophys. Acta 1778, 2717-2726 (2008).
25. Wakabayashi, M. & Matsuzaki, K. Ganglioside-induced amyloid formation by human islet amyloid polypeptide in lipid rafts. FEBS Lett. 583, 2854-2858 (2009).
26. McLean, C. A. et al. Soluble pool of Abeta amyloid as a determinant of severity of neurodegeneration in Alzheimer's disease. Ann Neurol. 46, 860-866 (1999).
27. Tamboli, I. Y., Prager, K., Barth, E., Heneka, M., Sandhoff, K. & Walter, J. Inhibition of glycosphingolipid biosynthesis reduces secretion of the beta-amyloid precursor protein and amyloid beta-peptide. J. Biol. Chem. 280, 28110-28117 (2005).
28. Marx, J. Alzheimer's disease. Fresh evidence points to an old suspect: calcium. Science 318, 384-385 (2007).
29. Bojarski, L., Herms, J. & Kuznicki, J. Calcium dysregulation in Alzheimer's disease. Neurochem Int. 52, 621-633 (2008).
30. Demuro, A., Parker, I. & Stutzmann, G. E. Calcium signaling and amyloid toxicity in Alzheimer disease. J. Biol. Chem. 285, 12463-12468 (2010).
31. Orrenius, S., Zhivotovsky, B. & Nicotera, P. Regulation of cell death: the calcium-apoptosis link. Nat. Rev. Mol. Cell. Bio. 4, 552-565 (2003).
32. Evangelisti, E. et al. Lipid rafts mediate amyloid-induced calcium dyshomeostasis and oxidative stress in Alzheimer's disease. Curr. Alzheimer Res. 10, 143-153 (2013).
33. Papadopoulos, N. G., Dedoussis, G. V., Spanakos, G., Gritzapis, A. D., Baxevanis, C. N. & Papamichail, M. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J. Immunol Meth. 177, 101-111 (1994).
34. Arispe, N., Diaz, J. C. & Simakova, O. Prospects for treating Alzheimer's disease with Abeta channel blockers. Biochim. Biophys. Acta 1768, 1952-1965 (2007).
35. Davidsson, P., Fredman, P. & Svennerholm, L. Gangliosides and sulphatide in human cerebrospinal fluid: quantitation with immunoaffinity techniques. J. Chromatogr. 496, 279-289 (1989).
36. Butterfield, S. M. & Lashuel H. A. Amyloidogenic protein-membrane interactions:mechanistic insight from model systems Angew. Chem. Int. Ed. 49, 5628-5654 (2010).
37. Kelly, B. I. & Ferreira A. Beta-amyloid-induced dynamin 1 degradation is mediated by N-methyl-D-aspartate receptors in hippocampal neurons. J. Biol. Chem. 281, 28079-28089 (2006).
38. Hsieh, H. et al. AMPARremoval underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52, 831-843 (2006).
39. Resende, R. et al. Susceptibility of hippocampal neurons to Abeta peptide toxicity is associated with perturbation of Ca2+ homeostasis. Brain Res. 1143, 11-21 (2007).
40. Liu, S. J. & Zukin, R. S. Ca2+-permeable AMPA receptors in synaptic plasticity and neuronal death, Trends Neurosci. 30, 126-134 (2007).
41. Shadek,G. M. et al. Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597-624). FASEB J. 20, 1254-1266 (2006).
42. He, P. et al. Tumor necrosis factor death receptor signaling cascade is required for amyloid-β protein-induced neuron death. J. Neurosci. 24, 1760-1771 (2004).
43. Yan, S. D. et al. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature 382, 685-691 (1996).
44. Lauren, J., Gimbel, D. A., Nygaard, H. B., Gilbert, J. W. & Strittmatter, S. M. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-β oligomers, Nature 457, 1128-1132 (2009).
45. Gunther, E. C. & Strittmatter, S. M. Alzheimer amyloid-beta oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat. neurosci. 15, 1227-1235 (2012).
46. Kostylev, M. A. et al. Prion-protein-interacting amyloid-β oligomers of high molecular weight are tightly correlated with memory impairment in multiple Alzheimer mouse models. J. Biol. Chem. 290, 17415-17438, (2015).
47. Hong, S. et al. Soluble Abeta oligomers are rapidly sequestered from brain ASF in vivo and bind GM1 ganglioside on cellular membranes. Neuron 82, 308-319 (2014).
48. Balducci, C. et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci. 107, 2295-2300 (2010).
49. Cissé, M., Sanchez, P. E., Kim, D. H., Ho, K., Yu, G. Q. & Mucke, L. Ablation of cellular prion protein does not ameliorate abnormal neural network activity or cognitive dysfunction in the J20 line of human amyloid precursor protein transgenic mice. J. Neurosci. 31, 10427-10431 (2011).
50. Cecchi, C. et al. Insights into the molecular basis of the differing susceptibility of varying cell types to the toxicity of amyloid aggregates. J. Cell. Sci. 118, 3459-3470 (2005).
51. Cecchi, C. et al. Replicating neuroblastoma cells in different cell cycle phases display different vulnerability to amyloid toxicity. J. Mol. Med. 86, 197-209 (2008).
52. Cizas, P. et al. Size-dependent neurotoxicity of β-amyloid oligomers. Arch. Biochem. Biophys. 496, 84-92 (2010).
53. Tanimura, A., Nezu, A., Morita, T., Turner, R. J. & Tojyo, Y. Fluorescent biosensor for quantitative real-time measurements of inositol 1,4,5,-triphosphate in single living cells. J. Biol. Chem. 279, 38095-38098 (2004).
54. Younkin, D. P. et al. Inducible expression of neuronal glutamate receptor channels in the NT2 human cell line. Proc. Natl. Acad. Sci. USA 90, 2174-2178 (1993).
55. De Felice, F. G. et al. Abeta oligomers induce neuronal oxidative stress through an N-methyl-D-aspartate receptor-dependent mechanism that is blocked by the Alzheimer drug memantine. J. Biol. Chem. 282, 11590-11601 (2007).